Wells Fargo’s Insmed INSM Stock Holding History

Wells Fargo’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-56,500	Closed	-$43K	–	6475
2019 Q4	$43K	Hold	56,500	–	–	﹤0.01%	5556
2019 Q3	$296K	Hold	56,500	–	–	﹤0.01%	4732
2019 Q2	$138K	Buy	+56,500	New	+$1.57M	﹤0.01%	5161
2019 Q1	–	Sell	-106,500	Closed	-$922K	–	6240
2018 Q4	$922K	Buy	+106,500	New	+$1.7M	﹤0.01%	3896

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wells Fargo's INSM Position: Q1 2026 in Review

Wells Fargo increased its Insmed (INSM) stake by 1.8% in Q1 2026, buying an estimated $1.65M and bringing the position to 597,384 shares worth $97.7M. The position accounts for 0.02% of the portfolio, ranked #642.

Wells Fargo first reported a position in INSM in Q4 2013 and has held it in 50 quarters since. The position peaked at $102M in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

Wells Fargo held 597,384 shares of Insmed worth $97.7M as of Q1 2026.
Wells Fargo bought 10,733 Insmed shares in Q1 2026, an estimated $1.65M.
Insmed made up 0.02% of Wells Fargo's portfolio in Q1 2026, its #642 holding.
Wells Fargo first reported a position in Insmed in Q4 2013 and has held it in 50 quarters since.
Wells Fargo's Insmed position peaked at $102M in Q4 2025.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.